Clinical Trial

Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

Study acronym: NEREUS
Recruiting
View on ClinicalTrials.gov →
Summary
Clinical and Demographic Characteristics of Adult Patients with NEurofibromatosis in RUSsia (NEREUS)
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2025-07-25; most recent amendment 2026-07-17.
Trial Details
NCT Number NCT07088991
Lead Sponsor AstraZeneca
Conditions Neurofibromatosis
Enrollment 200 participants
Start Date 2025-06-06
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20